-
2021
- Acute Hepatitis Panel 2021
- Allergy Testing 2021
- Alpha-fetoprotein (AFP) 2021
- Assays of Vitamins and Metabolic Function 2021
- Biomarkers for Oncology 2021
- Biomarkers Overview 2021
- Blood Counts 2021
- Blood Glucose Testing 2021
- Carcinoembryonic Antigen (CEA) 2021
- Collagen Crosslinks Any Method 2021
- Comprehensive Stool 2021
- Controlled Substance Monitoring and Drugs of Abuse Testing 2021
- C-Reactive Protein High Sensitivity Testing (hsCRP) 2021
- Cytogenetic Studies 2021
- Digoxin Therapeutic Drug Assay 2021
- Fecal Occult Blood Test 2021
- Flow Cytometry 2021
- Gamma Glutamyl Transferase 2021
- Glycated Hemoglobin Glycated Protein (Ha1CG) 2021
- Histocompatibility Testing 2021
- HPV guideline 1
- HPV guideline 2
- Human Chorionic Gonadotropin (Beta hcg) 2021
- Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 2021
- Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) 2021
- Lipid Panel 2021
- Molecular Diagnostics Genitourinary Infectious Disease Testing 2021
- PAP guidelines
- Partial Thromboplastin Time (PTT) 2021
- Prostate Specific Antigen (PSA) 2021
- Prothrombin Time (PT) 2021
- Serum Iron Studies 2021
- Sweat Test 2021
- Thyroid Testing 2021
- Tumor Antigen by Immunoassay CA 125 2021
- Tumor Antigen by Immunoassay CA 15-3 CA27.29 2021
- Tumor Antigen by Immunoassay CA 19-9 2021
- Urine Culture, Bacterial 2021
-
2020
- 1008_ICD10 Common Codes
- Acute Hepatitis Panel 2020.pdf
- Allergy Testing 2020.pdf
- Alpha Fetoprotein Serum 2020.pdf
- Assays of Vitamins and Metabolic Function 2020.pdf
- Biomarkers for Oncology 2020.pdf
- Biomarkers Overview 2020.pdf
- Blood Counts 2020.pdf
- Blood Glucose Testing 2020.pdf
- Carcinoembryonic Antigen (CEA) 2020.pdf
- Collagen Crosslinks, Any Method 2020.pdf
- Comprehensive Stool Guideline
- Controlled Substance Monitoring and Drugs of Abuse Testing 2020.pdf
- C-Reactive Protein High Sensitivity Testing (hsCRP) 2020.pdf
- Digoxin Therapeutic Drug Assay 2020.pdf
- Fecal Occult Blood Test 2020.pdf
- Flow Cytometry 2020.pdf
- Gamma Glutamyl Transferase (GGT) 2020.pdf
- Glycated Hemoglobin Glycated Protein (Ha1CG) 2020.pdf
- Human Chorionic Gonadotropin (beta hcg) 2020.pdf
- Human Immunodeficiency Virus (HIV) Testing (Diagnosis) 2020.pdf
- Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) 2020.pdf
- Lipid Panel 2020.pdf
- Molecular Diagnostics Genitourinary Infectious Disease Testing 2020.pdf
- Partial Thromboplastin Time (PTT) 2020.pdf
- Prostate Specific Antigen (PSA) 2020.pdf
- Prothrombin Time (PT) 2020.pdf
- Serum Iron Studies 2020.pdf
- Sweat Test 2020.pdf
- Thyroid Stimulating Hormone Testing 2020.pdf
- Tumor Antigen by Immunoassay CA 125 2020.pdf
- Tumor Antigen by Immunoassay CA 15-3 CA 27.29 2020.pdf
- Tumor Antigen by Immunoassay CA 19-9 2020.pdf
- Urine Culture, Bacterial 2020.pdf
Medicare Coverage Policies
The policies listed here are the Medicare Local Coverage Determinations (LCDs) and the National Coverage Determinations (NCDs) and are intended to be a quick reference, not a substitute for the complete LCDs, NCDs or the ICD-10 manual.
The complete policies may be accessed through Centers for Medicare and Medicaid Services.
Please refer to the ICD-10 manual for a complete listing of ICD-10 codes. The ultimate responsibility for correct coding lies with the ordering physician. All ICD-10 codes must be medically appropriate for the patient's condition and consistent with the information found in the patient's medical record for the date of service.
Most Medicare Advantage Plans follow these coverage policies. Please consult the specific Medicare Advantage carrier for confirmation.